Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Klotho Neurosciences, Inc. (KLTO)

NASDAQ

$--

(--)

Pre-Market

Klotho Neurosciences, Inc. (KLTO) Live Price Chart

Last updated: ⁦2026-09-09 11:18:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Klotho Neurosciences, Inc. (KLTO) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Klotho Neurosciences, Inc. (KLTO) Pre-Market Stock Price

Klotho Neurosciences, Inc. (KLTO) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing KLTO before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Klotho Neurosciences, Inc. (KLTO) 7-Day Stock Price Change

Over the past seven days, Klotho Neurosciences, Inc. (KLTO) moved from $0.66 to $0.52, representing a decline of 20.14% ($0.13).

The stock traded between $0.37 and $0.74 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 12.09 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Klotho Neurosciences, Inc. (KLTO)?

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Klotho Neurosciences, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	3
Exchange	NASDAQ
Company Website	https://www.klothoneuro.com

How to Buy Klotho Neurosciences, Inc. (KLTO) Stock on MEXC

Eligible investors can buy real shares of Klotho Neurosciences, Inc. (KLTO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KLTO and Place Your Order

Open the RealStocks trading page and search for KLTO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Klotho Neurosciences, Inc. (KLTO) stock price today?

Klotho Neurosciences, Inc. (KLTO) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is KLTO stock going up or down today?

As of --, KLTO is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is KLTO pre-market price?

As of --, KLTO is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KLTO after-hours price?

As of --, KLTO is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KLTO stock trading now?

KLTO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KLTO sit relative to its 52-week high and low?

Over the past 52 weeks, KLTO has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Klotho Neurosciences, Inc. in?

Klotho Neurosciences, Inc. (KLTO) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Klotho Neurosciences, Inc.'s market capitalization and where is it listed?

Klotho Neurosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KLTO valued in terms of P/E ratio and EPS?

KLTO trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Klotho Neurosciences, Inc. pay a dividend?

Klotho Neurosciences, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.